covid 19 News and Research

RSS

Study unveils several natural marine products as potential agents against SARS-CoV-2

A recent study, published in the Journal of Natural Products of the American Chemical Society and American Society of Pharmacognosy, highlighted three natural marine products as potent inhibitors of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – without any apparent toxic effects for human lung cells.

21 Mar 2022

Low levels of SARS-CoV-2 viremia associated with ‘COVID placentitis’ and stillbirths

Researchers hypothesize that patients with COVID placentitis were more likely to contract viremia.

20 Mar 2022

Sex-specific differences in T-cell responses to COVID-19

Researchers evaluate both neutralizing activity and T-cell responses in SARS-CoV-2 infected individuals with mild symptoms linked to a single spreading event.

20 Mar 2022

Multiple inter-variant recombination events identified in Omicron subvariants

Newly emerging and circulating Omicron subvariants have originated partially through recombination with other variants.

20 Mar 2022

Response to COVID-19 boosters in seronegative multiple sclerosis patients

Researchers report humoral T-cell responses in seronegative MS patients after receiving a third COVID-19 booster vaccine dose.

20 Mar 2022

How does the non-structural protein 1 affect COVID-19 pathogenicity?

Researchers discuss the effects of the SARS-CoV-2 non-structural protein 1 (Nsp1), which binds to the ribosomal subunit thus inhibiting translation.

20 Mar 2022

Cov2clusters: Novel method for producing stable genomic clusters of SARS-CoV-2 cases

Researchers present a novel method for producing stable genomic clustering of SARS-CoV-2 cases, Cov2clusters.

20 Mar 2022

Sinovac COVID vaccine shows modest efficacy against SARS-CoV-2 infection in children 3 to 5 years

Researchers investigate the efficacy of CoronaVac, COVID-19 vaccine developed by Sinovac Biotech, in children aged three to five years.

20 Mar 2022

Omicron BA.1.1 and BA.2 subvariants with new mutations in New Zealand and Hong Kong

A new study describes mutations found in the SARS-CoV-2 BA.1 variant in Hong Kong and New Zealand.

20 Mar 2022

Acidity of expiratory aerosols influences infectivity of SARS-CoV-2

Researchers provide insight on the potentially significant impact of aerosol pH on the transmission of SARS-CoV-2.

20 Mar 2022

NYU Long Island School Of Medicine's Class of 2022 discover their "doctor destinies" on Match Day

On Friday, March 18, NYU Long Island School of Medicine held its first Match Day, a ceremony that takes place at medical schools across the nation during which it is revealed where graduating students will fulfill their medical residencies.

18 Mar 2022

Natural circulating antibodies last for at least seven months in children infected with COVID-19

Children previously infected with COVID-19 develop natural circulating antibodies that last for at least seven months, according to a new study led by researchers at UTHealth Houston.

18 Mar 2022

Understanding how coronavirus, RS virus and rhinovirus affect children

When Inger Heimdal started studying the coronavirus in children in 2014, not many people thought the topic sounded particularly exciting.

18 Mar 2022

New study tracks food insecurity during the COVID-19 pandemic

In response to the rapid spread of COVID‐19, governments across the globe implemented local lockdowns that led to increased unemployment and disrupted local and international transport routes and supply chains.

18 Mar 2022

NYU Grossman School of Medicine’s graduating students matched into top residency programs

On Friday, March 18, after a two-year hiatus, graduating students at NYU Grossman School of Medicine gathered in person for Match Day 2022 to learn where they would be for the next phase in their medical training.

18 Mar 2022

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

As SARS-CoV-2 has continued to evolve and outsmart existing treatments, scientists have not let up looking for ever-more effective tools to keep people safe and successfully recover from COVID-19, and to prepare for future outbreaks.

18 Mar 2022

SARS-CoV-2 Delta variant-induced antibody response largely focuses on class 1 and 2 antibody epitopes

A new study evaluated the specificity of antibody response elicited by the Delta variant of SARS-CoV-2.

18 Mar 2022

Covalent protein nanobodies for neutralizing SARS-CoV-2 and its variants

Researchers developed covalent nanobodies to neutralize severe acute respiratory syndrome coronavirus-2 and its variants.

18 Mar 2022

Study evaluates COVID-19 vaccination with recombinant accessory protein-deficient SARS-CoV-2

Researchers assessed the impact of recombinant accessory protein-deficient severe acute respiratory syndrome coronavirus 2 immunization against SARS-CoV-2 transmission and disease severity.

18 Mar 2022

Presence of zoonotic pathogens in wildlife market for human consumption in Laos

Researchers from different countries examined various animal species from wildlife trade sites to detect the presence of zoonotic pathogens in Laos, South East Asia.

18 Mar 2022

covid 19 News and Research

Study unveils several natural marine products as potential agents against SARS-CoV-2

Low levels of SARS-CoV-2 viremia associated with ‘COVID placentitis’ and stillbirths

Sex-specific differences in T-cell responses to COVID-19

Multiple inter-variant recombination events identified in Omicron subvariants

Response to COVID-19 boosters in seronegative multiple sclerosis patients

How does the non-structural protein 1 affect COVID-19 pathogenicity?

Cov2clusters: Novel method for producing stable genomic clusters of SARS-CoV-2 cases

Sinovac COVID vaccine shows modest efficacy against SARS-CoV-2 infection in children 3 to 5 years

Omicron BA.1.1 and BA.2 subvariants with new mutations in New Zealand and Hong Kong

Acidity of expiratory aerosols influences infectivity of SARS-CoV-2

NYU Long Island School Of Medicine's Class of 2022 discover their "doctor destinies" on Match Day

Natural circulating antibodies last for at least seven months in children infected with COVID-19

Understanding how coronavirus, RS virus and rhinovirus affect children

New study tracks food insecurity during the COVID-19 pandemic

NYU Grossman School of Medicine’s graduating students matched into top residency programs

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

SARS-CoV-2 Delta variant-induced antibody response largely focuses on class 1 and 2 antibody epitopes

Covalent protein nanobodies for neutralizing SARS-CoV-2 and its variants

Study evaluates COVID-19 vaccination with recombinant accessory protein-deficient SARS-CoV-2

Presence of zoonotic pathogens in wildlife market for human consumption in Laos

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News